research Infundibular Protein and RNA Microarray Analyses from Affected and Clinically Non-Affected Scalp in Male Androgenetic Alopecia Patients
Finasteride helps female-pattern hair loss.
Search
for
Sort by
Research
420-450 / 1000+ results 
research Morning Periorbital Edema Due to Low Dose Oral Minoxidil
Low doses of oral minoxidil, a hair loss treatment, can cause temporary morning swelling around the eyes, but it's not serious and can disappear with continued use or dose adjustment.
research Nonablative Radiofrequency for the Treatment of Androgenetic Alopecia: An Open-Label Study
Nonablative radiofrequency therapy improves hair density, thickness, and growth rate.
research Platelet Rich Plasma in Androgenetic Alopecia: A Prospective Study
Platelet Rich Plasma (PRP) treatment effectively reduces hair fall and increases hair growth in patients with Androgenetic Alopecia (AGA), but it may cause pain.
research Platelet-Rich Plasma with Low Dose Oral Minoxidil (1.25 mg Versus 2.5 mg) Along with Trichoscopic Pre- and Post-Treatment Evaluation
Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.
research Platelet-Rich Plasma and Microneedling Improve Hair Growth in Patients with Androgenetic Alopecia When Used as an Adjuvant to Minoxidil
Combining platelet-rich plasma, microneedling, and minoxidil improves hair growth.
research The Role of Oxidative Stress in Early-Onset Androgenetic Alopecia
Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.
research Evidence of Increased DNA Methylation of the Androgen Receptor Gene in Occipital Hair Follicles from Men with Androgenetic Alopecia
Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.
research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors
Hair loss increases with age; alcohol raises risk, more female partners lowers it.
research Oral Cyclosporin Does Not Arrest Progression of Androgenetic Alopecia
Oral cyclosporin doesn't stop hair loss.
research Frequency of Body Dysmorphic Disorder Among Patients With Complaints of Hair Loss
Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.
research Alopecia and the Microbiome: A Future Therapeutic Target?
The microbiome may be linked to hair loss and could be a target for new treatments.
research Favorable Effects of Microneedling on Long-Standing Androgenetic Alopecia in an Elderly Man: A Case Report
Microneedling with minoxidil improved hair growth in elderly man.
research Oral Cyclosporin Does Not Arrest Progression of Androgenetic Alopecia
Cyclosporin doesn't stop hair loss.
research Hair Loss After Terbinafine Treatment
Terbinafine can cause hair loss.
research An Herbal Extract Combination (Biochanin A, Acetyl Tetrapeptide-3, and Ginseng Extracts) Versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-Week, Prospective, Randomized, Triple-Blind, Controlled Trial
The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.
research Low-Level Laser Therapy and Narrative Review of Other Treatment Modalities in Androgenetic Alopecia
LLLT is a safe, promising hair loss treatment, but more research needed.
research Effect of Platelet Counts and Activator in Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia, Split-Head Comparison: A Randomised, Double-Blind Study
Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.
research Baldness, Acne, and Testicular Germ Cell Tumors
Men with testicular cancer were less likely to experience baldness and severe acne.
research Evaluation of Non-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems
PRP treatment improves hair growth, and the device used can affect results, with some being more effective.
research Androgenetic Alopecia: Quality of Life and Associated Lifestyle Patterns
Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.
research Lipid Profile in Patients with Androgenetic Alopecia: A Meta-Analysis
People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.
research Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia: A Double-Blind Half-Head Controlled Trial
Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.
research Cetuximab-Induced Hypertrichosis of the Scalp and Eyelashes
A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.
research Androgenetic Alopecia as a Marker of Metabolic Syndrome
Balding in men might indicate a higher risk of metabolic health issues.
research New-Onset Androgenic Alopecia Following Human Chorionic Gonadotropic Diet and Testosterone Pellet Implantation
The hCG diet and testosterone therapy can cause hair loss in some people.
research Paired Ear Creases of the Helix: A Possible Physical Sign
Ear creases might indicate heart disease risk, needing more research.
research Platelet-Rich Plasma Injections in the Treatment of Male Androgenetic Alopecia: A Randomized Placebo-Controlled Crossover Study
PRP injections improve hair density in male hair loss.
research Follicular Unit Extraction Megasession Treatment of High-Grade Androgenetic Alopecia in Asians: Introducing Novel Principles for Surgical Design
The new follicular unit extraction treatment effectively treats severe hair loss in Asian men, giving natural-looking results with few side effects.
research Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.